IRF4 and plasma cell myeloma: Although deletion of Cereblon (CRBN), a target of iMiDs linked with interferon regulatory factor 4 (IRF4), has been associated with iMiD resistance in myeloma, the mechanism of iMiD resistance in PCNSL has not yet been clarified [102].